View More Recent Stories
-
Jones Trading Reiterates Buy Rating on Prime Medicine (PRME)
-
Prime Medicine (PRME) Unveils Strategically Focused Pipeline
-
Prime Medicine (PRME) Announces Strategic Research Collaboration and License Agreement with Bristol Myers Squibb to Develop and Commercialize Multiple Prime Edited Ex Vivo T-Cell Therapies
-
Prime Medicine, Inc. (PRME) Tops Q2 EPS by 3c


